A Review of the Literature on the Selegiline Transdermal System

• Not rated yet.
• 

The selegiline transdermal system provides several advantages compared to orally administered MAOIs, including minimal interaction with dietary tyramine and prolonged exposure to the parent compound, while offering a favorable side effect profile. As a result, treatment at the lowest effective dose of 6 mg/24 hours can be administered without the need for dietary modifications.

• Web Address: http://www.psychiatrist.com/pcc/abstracts/abstracts.asp?abstract=pcc100103.htm
• Short Name: whawizare
• Short Link: http://ma.gnolia.com/whawizare
• Tags: None assigned
• Saved by Joseph j7uy5 on April 08, 2008.
• Bookmark licensed under Creative Commons Attribution Non-commercial Share Alike 2.5.